Survey on the occasion of diagnosis and prognosis of treatment of prolactinomas

Survey on the occasion of diagnosis and prognosis of treatment of prolactinomas - Survey on the occasion of diagnosis and prognosis of treatment of prolactinomas

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049628

Enrollment

100

Registered

2025-03-31

Start date

2022-12-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prolactinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with prolactinomas aged 20 years or older

Exclusion criteria

Exclusion criteria: Subjects deemed inappropriate as research subjects by the principal investigator

Design outcomes

Primary

Measure	Time frame
Prolactinoma Treatment Outcomes	—

Secondary

Measure	Time frame
1) Prognosis of treatment of prolactinomas in relation to blood test parameters 2) Prognosis of prolactinoma in relation to imaging parameters 3) Prognosis of treatment of prolactinomas in relation to the occasion of diagnosis 4) Prognosis of treatment of prolactinoma in relation to treatment details	—

Countries

Japan

Contacts

Public ContactTaisuke Uchida

Department of Internal Medicine, Faculty of Internal Medicine, University Division of Hematology, Diabetes, and Endocrinology

taisuke_uchida@med.miyazaki-u.ac.jp0985859121

Outcome results